Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gogas

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
The British Journal of Dermatology|August 2, 2011
Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanomaV Nikolaou, X Kang, A Stratigos, et al.
The British Journal of Dermatology|January 17, 2007
p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variantsI Stefanaki, A J Stratigos, G Dimisianos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology GroupH Gogas, C Papadimitriou, H P Kalofonos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2005
Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, D Tsoutsos, H Kalofonos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology GroupN Xiros, P Papacostas, T Economopoulos, et al.
British Journal of Cancer|March 5, 2002
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancerT R J Evans, K W Colston, F J Lofts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 29, 2019
Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patientsVasiliki Nikolaou, D Voudouri, G Tsironis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II studyG Fountzilas, D Tsavdaridis, A Kalogera-Fountzila, et al.
Anticancer Research|January 25, 2008
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyP Kosmidis, G Fountzilas, S Baka, et al.
The British Journal of Dermatology|April 23, 2014
Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence populationJ A Talaganis, K Biello, M Plaka, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
The British Journal of Dermatology|August 2, 2011
Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanomaV Nikolaou, X Kang, A Stratigos, et al.
The British Journal of Dermatology|January 17, 2007
p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variantsI Stefanaki, A J Stratigos, G Dimisianos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology GroupH Gogas, C Papadimitriou, H P Kalofonos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2005
Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, D Tsoutsos, H Kalofonos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology GroupN Xiros, P Papacostas, T Economopoulos, et al.
British Journal of Cancer|March 5, 2002
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancerT R J Evans, K W Colston, F J Lofts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 29, 2019
Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patientsVasiliki Nikolaou, D Voudouri, G Tsironis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II studyG Fountzilas, D Tsavdaridis, A Kalogera-Fountzila, et al.
Anticancer Research|January 25, 2008
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyP Kosmidis, G Fountzilas, S Baka, et al.
The British Journal of Dermatology|April 23, 2014
Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence populationJ A Talaganis, K Biello, M Plaka, et al.
Pageof 8